- Home
- / Chenguang Biotech Group
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Chenguang Biotech Group financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
¥6 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.6B | 2.9B | 3.2B | 4.0B | 5.1B | 5.7B | 5.8B | 6.0B |
| Cost of goods sold | 2.6B | 2.7B | 3.3B | 4.2B | 5.4B | 6.1B | 6.4B | 5.7B |
| Gross profit | 428.7M | 571.1M | 639.9M | 705.4M | 860.9M | 781.1M | 537.7M | 834.9M |
| Gross profit margin, % | 16.6% | 20.0% | 19.9% | 17.8% | 17.0% | 13.8% | 9.3% | 13.9% |
| Operating expense total | 172.9M | 235.6M | 176.2M | 197.2M | 255.8M | 172.6M | 181.1M | 233.6M |
| Depreciation and amortization | 75.5M | 88.5M | 109.6M | 135.2M | 145.4M | 153.6M | 166.8M | 182.2M |
| EBITDA | 255.8M | 340.9M | 473.9M | 526.2M | 625.4M | 621.6M | 365.2M | 613.6M |
| EBITDA margin, % | 9.9% | 11.9% | 14.7% | 13.3% | 12.4% | 11.0% | 6.3% | 10.2% |
| EBIT | 193.5M | 263.2M | 372.1M | 418.5M | 486.0M | 534.5M | 161.4M | 449.3M |
| EBIT margin, % | 7.5% | 9.2% | 11.6% | 10.6% | 9.6% | 9.5% | 2.8% | 7.5% |
| Interest income | 3.5M | 4.9M | 16.6M | 9.2M | 24.8M | 35.6M | 40.6M | 38.5M |
| Interest expense | 46.1M | 65.5M | 78.1M | 53.1M | 67.2M | 83.5M | 114.4M | 90.8M |
| Pre tax profit | 151.0M | 210.6M | 312.6M | 398.1M | 501.8M | 555.8M | 106.9M | 437.9M |
| Income tax expense | 8.6M | 20.7M | 46.5M | 47.5M | 65.7M | 61.6M | 29.0M | 63.0M |
| Net Income | 142.4M | 189.9M | 266.1M | 350.6M | 436.1M | 494.2M | 78.0M | 374.9M |